Sequence CLCN1 and SCN4A genes in patients with nondystrophic myotonia in Chinese people. Issue 29 (22nd July 2022)

• Record Type: Journal Article
• Authors: Meng, Yan-Xin; Yu, Mei; Liu, Chunmiao; Zhang, Haijuan; Yang, Yuxiu; Zhang, Jing
• Is Part Of: Medicine. Volume 101:Issue 29(2022)
• Page Start: e29591
• Publication Date: 2022-07-22
• Subjects: CLCN1 -- nondystrophic myotonias -- novel mutations -- SCN4A; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000029591
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract : Background: This study aimed to characterize the genetic, pathological, and clinical alterations of 17 patients in China presenting with nondystrophic myotonia (NDM) and to analyze the relationship between genotype and clinical phenotype. Methods: CLCN1 and SCN4A genes in patients with clinical features and muscle pathology indicative of NDM were sequenced. Furthermore, KCNE3 and CACNA1S genes were assessed in patients with wild-type CLCN1 and SCN4A. Results: Patients may have accompanying atypical myopathy as well as muscle hypertrophy, secondary dystonia, and joint contracture as determined by needle electromyography. All the study participants were administered mexiletine in combination with carbamazepine and showed significant improvements in myotonia symptoms in response to this therapy. CLCN1 gene mutation was detected in 8 cases diagnosed with myotonia congenital using gene screening. The detected mutations included 5 missense, 2 nonsense, 1 deletion, and 2 insertions. Further gene analysis showed 4 mutations in the SCN4A gene in patients diagnosed with paramyotonia congenita. Conclusions: Myotonia congenita and paramyotonia congenita are the predominant forms of NDM in China. NDM may be best diagnosed using genetic analysis in associated with clinical features.